PEnile ReHABilitation After Nerve Sparing Robot-assisted Radical Prostatectomy for Prostate Cancer 2.0 (PEHAB-II)

The PEHAB-II study is prospective, randomized trial designed to assess the effect of two different rehabilitation strategies on the recovery of erectile function in nerve sparing prostatectomy patients. The two rehabilitation strategies consist of 1)12 months daily doses of 100 mg Sildenafil combined with vacuum device (VED) therapy for 10 minutes a day, five times a week or 2) Standard of care: monotherapy with an on-demand dosage of 100mg Sildenafil. The study will be performed in multiple centers in the Netherlands.

Trial Details

NCT ID
NCT06875258
Phase
PHASE4
Sponsor
The Netherlands Cancer Institute
Status
RECRUITING
Cancer Type
Prostate Cancer
Interventions
  • Sildenafil
  • Erectile vacuum device
Locations (sample)
  • Nijmegen, Gelderland, Netherlands|51.8425,5.85278
  • Amsterdam, North Holland, Netherlands|52.37403,4.88969
  • Rotterdam, South Holland, Netherlands|51.9225,4.47917

Key Eligibility Criteria

  • Pre-screening eligibility criteria
  • Age \> 18 years and \< 70 years
  • Patients who have a penis that has developed naturally, without surgical interventions.
  • Histologically confirmed PCa

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Prostate Cancer Trials on Trialify →